RCK’s feature in The Times: Lord Philip Hammond joining as a Senior Advisor

Understand the potential tax savings that may be available to BTR and PBSA owners.

Former HMRC R&D Compliance Officer and current RCK HMRC Liaison, Alex Marshall, shares his insight on how compliance is everything when claiming R&D tax relief. Compliance within the R&D tax relief scheme has never been more important, with the results of HMRC’s Mandatory Random Enquiry Programme (MREP), outlining greater levels of error and fraud than previously expected, resulting in a major overhaul in activity to tackle non-compliance. But how did we get here?

With the contagious outbreak announced as a global medical emergency, the pandemic provided a new challenge for pharmaceutical companies to make an impact, looking to streamline drug development, decentralise testing centres and develop new assured point-of-care testing.